Coeptis Therapeutics, Inc. Interest Expense
Coeptis Therapeutics, Inc. reported Interest Expense of $56.42 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2022-11-08
- Coeptis Therapeutics, Inc. interest expense for the quarter ending 2022-09-30 was $56.42K, a 70.08% decline year-over-year.
- Coeptis Therapeutics, Inc. interest expense for the quarter ending 2022-06-30 was $63.83K, a 48.10% increase year-over-year.
- Coeptis Therapeutics, Inc. interest expense for the quarter ending 2022-03-31 was $55.82K, a 60.69% increase year-over-year.
- Coeptis Therapeutics, Inc. interest expense for the quarter ending 2021-12-31 was -$79.25K.
- Coeptis Therapeutics, Inc. interest expense for fiscal 2021 was $187.13K, a 26.28% increase from fiscal 2020.
- Coeptis Therapeutics, Inc. interest expense for fiscal 2020 was $148.19K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2022-09-30 | $56.42K 10-Q · filed 2022-11-08 | $120.25K derived: sum of 2 quarters · filed 2022-11-08 | $176.07K 10-Q · filed 2022-11-08 | $96.82K derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-06-30 | $63.83K 10-Q · filed 2022-08-02 | $119.64K 10-Q · filed 2022-08-02 | $40.40K derived: sum of 3 quarters · filed 2022-08-02 | $228.96K derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-03-31 | $55.82K 10-Q · filed 2022-05-12 | -$23.43K derived: sum of 2 quarters · filed 2022-05-12 | $165.13K derived: sum of 3 quarters · filed 2022-11-08 | $208.23K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-12-31 | -$79.25K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $109.31K derived: sum of 2 quarters · filed 2022-11-08 | $152.41K derived: sum of 3 quarters · filed 2022-11-08 | $187.13K 10-K · filed 2022-03-11 |
| 2021-09-30 | $188.56K 10-Q · filed 2022-11-08 | $231.66K derived: sum of 2 quarters · filed 2022-11-08 | $266.38K 10-Q · filed 2022-11-08 | $151.76K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $43.10K 10-Q · filed 2022-08-02 | $77.82K 10-Q · filed 2022-08-02 | -$36.80K derived: sum of 3 quarters · filed 2022-08-02 | $147.07K derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $34.74K 10-Q · filed 2022-05-12 | -$79.90K derived: sum of 2 quarters · filed 2022-05-12 | $103.97K derived: sum of 3 quarters · filed 2022-05-12 | $140.31K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$114.63K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $69.24K derived: sum of 2 quarters · filed 2022-03-11 | $105.58K derived: sum of 3 quarters · filed 2022-03-11 | $148.19K 10-K · filed 2022-03-11 |
| 2020-09-30 | $183.87K 10-Q · filed 2021-11-15 | $220.21K derived: sum of 2 quarters · filed 2021-11-15 | $262.83K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $36.34K 10-Q · filed 2021-08-16 | $78.95K 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $34.50K 10-Q/A · filed 2021-05-18 |